1-4 of 4
Elie Fares
Close
Sort by
Journal Articles

Bendamustine Demonstrates Promising Activity in Post-Brentuximab Failure Hodgkin Lymphoma Patients Who Had Also Failed a Prior Autologous HCT and Facilitates Successful Bridging to Allogeneic HCT

Jean Elcheikh, MD, Radwan Massoud, MD, Elie Fares, Mohamed A Kharfan-Dabaja, MD, Jisr Tamima, MD, Anas Mougharbel, MD, Ali Bazarbachi, MD PhD, Ahmad Ibrahim
Journal: Blood
Blood (2016) 128 (22): 5359.
https://doi.org/10.1182/blood.V128.22.5359.5359
Published: 2016
Journal Articles

Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)

Radwan Massoud, MD, Rita Assi, MD, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Souha Kanj, Aline El-Zakhem, Mohamed A. Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5824.
https://doi.org/10.1182/blood.V128.22.5824.5824
Published: 2016
Journal Articles

Azacitidine As Post-Allograft Maintenance Helps Reduce Relapse Risk in High-Risk MDS and AML

Jean El Cheikh, MD PhD, Radwan Massoud, Elie Fares, Nabila Kreidieh, Rami Mahfouz, Mohamed A Kharfan-Dabaja, MD, Ali Bazarbachi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5872.
https://doi.org/10.1182/blood.V128.22.5872.5872
Published: 2016
Journal Articles

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Amanda Chidiac, Radwan Massoud, MD, Mohamad Haidar, Elie Fares, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5357.
https://doi.org/10.1182/blood.V128.22.5357.5357
Published: 2016